Preventive immunization against respiratory infections in patients with cystic fibrosis
https://doi.org/10.18093/0869-0189-2017-28-6-746-753
Abstract
This article is a review highlighting the current role of preventive immunization in patients with cystic fibrosis (CF). Clinical, pathogenic, and epidemiological aspects supporting the preventive immunization were described in the article. Different approaches and results of different vaccination schedules according to the respiratory pathogens were also analyzed. Based on this analysis, the authors developed the optimal schedule of preventive vaccination. Published results confirm the efficacy of vaccination against respiratory infections in CF patients not only as a preventive measure but as an important part of combined therapy of this disease. This is an attractive approach to improve the efficacy of the treatment and survival of CF patients.
About the Authors
D. A. Blagovidov
I.I.Mechnikov Federal Research Institute of Vaccines and Sera, Russian Academy of Science
Russian Federation
Competing Interests: No conflict of interest
Russian Federation
Dmitriy A. Blagovidov - Junior Researcher, Laboratory of Preventive Vaccination and Immune Therapy of Allergic Diseases.
Malyy Kazennyy per. 5A, Moscow, 105064, tel.: (963) 782-35-23
Competing Interests: No conflict of interest
K. V. Mashilov
I.I.Mechnikov Federal Research Institute of Vaccines and Sera, Russian Academy of Science
Russian Federation
Competing Interests: No conflict of interest
Russian Federation
Kirill V. Mashilov - Candidate of Medicine, Associate Professor, Senior Researcher, Laboratory of Preventive Vaccination and Immune Therapy of Allergic Diseases.
Malyy Kazennyy per. 5A, Moscow, 105064, tel.: (925) 985-14-24
Competing Interests: No conflict of interest
A. M. Kostinov
M.V.Lomonosov Moscow Federal State University
Russian Federation
Competing Interests: No conflict of interest
Russian Federation
Anton M. Kostinov - the 4th year student.
Leninskie gory 1, Moscow, 119991,tel.: (916) 618-81-05
Competing Interests: No conflict of interest
References
1. Kondrat'eva E.I., Krasovskiy S.A., eds. A Register of Patients with Cystic Fibrosis in Russian Federation. 2015. Moscow: Medpraktika-M; 2016 (in Russian).
2. Kondrat'eva E.I., Kashirskaya N.Yu., Kapranov N.I., eds. Cystic Fibrosis: Definition, Diagnostic Criteria, and Therapy. A National Consensus. Moscow: Borges; 2016 (in Russian).
3. Kapranov N.I., Kashirskaya N.Yu., eds. Cystic Fibrosis. Moscow: Medpraktika-M; 2014 (in Russian).
4. Simonova O.I., Lazareva A.V., Motuzova O.V. et al. New abilities of antibacterial treatment in acute and chronic respiratory disorders in children. Voprosy sovremennoy pediatrii. 2013; 12 (1): 123–130. DOI: 10.15690/vsp.v12i1.568 (in Russian).
5. Shaginyan I.A., Kapranov N.I., Chernukha M.Yu. et al. Lower airway microbiota in children with cystic fibrosis in dependence to age. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2010; (1): 15–20 (in Russian).
6. Hauser A.R., Jain M., Bar-Meir M., McColley S.A. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin. Microbiol. Rev. 2011; 24 (1): 29–70. DOI: 10.1128/CMR.00036-10.
7. Cystic Fibrosis Foundation. Patient Registry. Annual Data Report 2007. Bethesda, 2008. Available at: http://www.cysticfibrosisdata.org/LiteratureRetrieve.aspx?ID=132649 [Accessed September 22, 2016].
8. Guss A.M., Roeselers G., Newton I.L.G. et al. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J. 2011; 5 (1): 20–29. DOI: 10.1038/ismej.2010.88.
9. Høiby N. Microbiology of lung infections in cystic fibrosis patients. Acta Paediatrica. Scand. 1982; 71 (Suppl. 301): 33–54. DOI: 10.1111/j.1651-2227.1982.tb09640.x.
10. Høiby N., Frederiksen B. Microbiology of cystic fibrosis. In: Hodson M.E., Geddes D., eds. Cystic Fibrosis. London: Arnold; 2000: 83–108.
11. Koch C. Early infection and progression of cystic fibrosis lung disease. Pediatr. Pulmonol. 2002; 34 (3): 232–236. DOI: 10.1002/ppul.10135.
12. Kosorok M.R., Zeng L., West S.E. et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr. Pulmon. 2001; 32 (4): 277–287.
13. Kashirskaya N.Yu., Kapranov N.I. Inhaled antibacterial agents in patients with cystic fibrosis. Atmosfera. Pul'monologiya i allergologiya. 2012; (3): 5–12 (in Russian).
14. Ebbing R., Robertson C.F., Robinson P.J. Haemophilus influenzae and Haemophilus parainfluenza in cystic fibrosis: 15 years experience. J. Med. Microbiol. Diagnos. 2015; S5: 004. DOI: 10.4172/2161-0703.S5-004.
15. Cardines R., Giufrè M., Pompilio A. et al. Haemophilus influenzae in children with cystic fibrosis: antimicrobial susceptibility, molecular epidemiology, distribution of adhesins and biofilm formation. Int. J. Med. Microbiol. 2012; 302 (1): 45–52. DOI: 10.1016/j.ijmm.2011.08.003.
16. Nisevich L.L., Sereda E.V., Selyutina N.S. et al. Viral infections in children with cystic fibrosis. Pediatricheskaya farmakologiya. 2011; 8 (2): 43–48 (in Russian).
17. Wang E.E., Prober C.G., Manson B. et al. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N. Engl. J. Med. 1984; 311 (26): 1653–1658. DOI: 10.1056/NEJM198412273112602.
18. Hiatt P.W., Grace S.C., Kozinetz C.A. et al. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics. 1999; 103 (3): 619–626.
19. Goffard A., Lambert V., Salleron J. et al. Virus and cystic fibrosis: rhinoviruses are associated with exacerbations in adult patients. J. Clin. Virol. 2014; 60 (2): 147–153. DOI: 10.1016/j.jcv.2014.02.005.
20. Bucher J., Boelle P.Y., Hubert D. et al. Lessons from a French collaborative case–control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy. BMC Infect. Dis. 2016; 16: 55. DOI: 10.1186/s12879-016-1352-2.
21. Protasov A.D., Zhestkov A.V., Lavrent'eva N.E. et al. Effects of complex vaccination against pneumococcus, Haemophilus influenzae type B, and influenza infections in patients with chronic obstructive pulmonary disease. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2011; (4): 80–84 (in Russian).
22. Protasov A.D., Ryzhov A.A., Zhestkov A.V., Kostinov M.P. An influence of complex vaccination against pneumococcus, Haemophilus influenzae type B, and influenza infecions on the clinical course of chronic obstructive pulmonary disease. Vestnik sovremennoy klinicheskoy meditsiny. 2012; 5 (2): 22–24 (in Russian).
23. Kоstinov M.P., Protasov A.D., Zhestkov A.V. et al. Post-vaccination immunity to Pneumococcal, Haemophilus Influenzae type B infection and influenza in patients with chronic obstructive pulmonary disease (COPD). J. Vaccin. Vaccinat. 2014, 5: 221. DOI: 10.4172/2157-7560.1000221.
24. Bukowska D., Serafińska D., Rudowski W. et al. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers.] Pol. Tyg. Lek. 1989; 44 (43–45): 924–927 (in Polish).
25. Kostinov M.P., ed. From prevention to therapeutic effect of vaccination against pneumococcus and Haemophilus influenzae type B infections in patients with respiratory diseases. Moscow: Zdorov'e cheloveka; 2007 (in Russian).
26. Thornton C.S., Brown E.L., Alcantara J. et al. Prevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study. BMC Pulm. Med. 2015; 15: 49. DOI: 10.1186/s12890-015-0041-z.
27. Esposito S., Colombo C., Tosco A. et al. Streptococcus pneumoniae oropharyngeal colonization in children and adolescents with cystic fibrosis. J. Cyst. Fibros. 2016; 15 (3): 366–371. DOI: 10.1016/j.jcf.2015.05.008.
28. Maeda Y., Elborn J.S., Parkins M.D. et al. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF). J. Cyst. Fibros. 2011; 10 (2): 133–139. DOI: 10.1016/j.jcf.2010.11.003.
29. del Campo R., Morosini M.I., de la Pedrosa E.G. et al. Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. J. Clin. Microbiol. 2005; 43 (5): 2207–2214. DOI: 10.1128/JCM.43.5.2207-2214.2005.
30. Lahiri T., Waltz D.A. Preimmunization anti-pneumococcal antibody levels are protective in a majority of patients with cystic fibrosis. Pediatrics. 2001; 108 (4): Е62. DOI: 10.1542/peds.108.4.e62.
31. Pneumococcal. In: Green Book. UK: National Health Service. 2013; 25 (5): 295–314. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/263318/Green-Book-Chapter-25-v5_2.pdf [Accessed September 22, 2016].
32. Kostinov M.P., ed. News in Clinical Course, Diagnostics and Preventive Vaccination against Controlled Infections. Moscow: Meditsina; 1997 (in Russian).
33. Kostinov M.P., ed. Vaccination of Children with Health Impairments. A Practical Handbook for Physicians. The 1st Edition. Moscow: Meditsina dlya vsekh; 1996 (in Russian).
34. Kostinov M.P., ed. Vaccination of Children with Health Impairments. A Practical Handbook for Physicians. The 2nd Edition. Moscow: Meditsina dlya vsekh; 2000 (in Russian).
35. Kostinov M.P., Ozeretskovskiy N.A., eds. Clinical and Immunological Efficacy of Immunobiological Agents: Handbook. Moscow: Miklosh; 2004 (in Russian).
36. Kostinov M.P., ed. Vaccination of Children with Health Impairments. A Practical Handbook for Physicians. The 4th Edition. Moscow: 4Mpress; 2013 (in Russian).
37. Kostinov M.P., ed. Vaccination of adults with respiratory diseases: A Practical Handbook for Physicians. Moscow: Sozvezdie; 2013 (in Russian).
38. Kostinov M.P., Chuchalin A.G., eds. A Handbook on Clinical Immunology in Respiratory Medicine. The 1st Edition. Moscow: ATMO; 2016 (in Russian).
39. Briko N.I., Namazova-Baranova L.S., Kostinov M.P., et al. Epidemiology, Clinics, and Prevention of Pneumococcal Infection. A Study Guide for Physicians. Nizhniy Novgorod: Remedium Privolzh'e; 2017 (in Russian).
40. Kobayashi M., Bennett N.M., Gierke R. et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly Rep. 2015; 64 (34): 944–947. DOI: 10.15585/mmwr.mm6434a4.
41. Burgess L., Southern K.W. Pneumococcal vaccines for cystic fibrosis. Cochrane Database Syst. Rev. 2014; (8): CD008865. DOI: 10.1002/14651858.CD008865.pub3.
42. Malfroot A., Adam G., Ciofu O. et al. Immunisation in the current management of cystic fibrosis patients. J. Cyst. Fibros. 2005; 4 (2): 77–87. DOI: 10.1016/j.jcf.2004.10.003.
43. Kostinov M.P., ed. Pneumo-23 and Akt-HIB Vaccines for the Therapy of Chronic Inflammatory Lung Diseases in Children: A Practical Handbook for Physicians. Moscow: Meditsina dlya vsekh; 2004 (in Russian).
44. Ong E. L. Bilton D., Abbott J. et al. Influenza vaccination in adults with cystic fibrosis. Br. Med. J. 1991; 303 (6802): 557.
45. Gross P.A., Denning C.R., Gaerlan P.F. et al. Annual influenza vaccination: immune response in patients over 10 years. Vaccine. 1996; 14 (13): 1280–1284. DOI: 10.1016/S0264-410X(96)00004-7.
46. Dharmaraj P., Tan A.A., Smyth R.L. Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database Syst. Rev. 2000; (1): CD001753. DOI: 10.1002/14651858.CD001753.
47. Kashirskaya N.Yu., Dashchinskaya O.V., Kapustina T.Yu. et al. An experience of vaccination of children with cystic fibrosis with Influvac vaccine. Farmateka. 2003; 13: 74–77 (in Russian).
48. Kostinov M.P., Maleev V.V. Haemophilus influenzae type B infections: issues of preventive vaccination. Moscow: Meditsina dlya vsekh; 1998 (in Russian).
49. Il'enko L.I., Kostinov M.P., Garashchenko M.V. et al. Vaccination against pneumococcus, Haemophilus influenzae and flu infections in children with frequently recurrent acute respiratory infections. Voprosy sovremennoy pediatrii. 2006; 5 (4): 27–30 (in Russian).
50. Yushkova I.Yu., Kostinov M.P., Filatova I.N. et al. Efficacy of vaccination against Haemophilus influenzae infection in children at closed communities. Detskie infektsii. 2004; 4: 34–36. (in Russian).
51. Kostinov M.P., Lavrov V.F. New-generation vaccines for prevention of infectious diseases. The 2nd Updated Edition. Moscow: MDV; 2010 (in Russian).
52. WHO. Haemophilus influenzae type b (Hib) Vaccination WHO position paper: July 2013-Recommendations. Vaccine. 2013; 31 (52): 6168–6169. DOI: 10.1016/j.vaccine.2013.10.045.
Review
For citations:
Blagovidov D.A., Mashilov K.V., Kostinov A.M. Preventive immunization against respiratory infections in patients with cystic fibrosis. PULMONOLOGIYA. 2018;28(6):746-753. (In Russ.) https://doi.org/10.18093/0869-0189-2017-28-6-746-753
Views:
959
Email this article 